EIAgen GI Marker CA 19-9

brief description

The CA 19-9 is a carbohydrate antigen predominantly associated with gastrointestinal (GI) malignancies; pancreatic, colorectal, gastric and hepatic carcinomas (1-2-3). The main application of CA 19-9 is in the management of diagnosed pancreatic and colorectal cancers (4-5-6). Immunochemically, CA 19-9 antigen is the sialated form of the blood group antigen Lewis (7-8). Clinical studies indicate that CA 19-9 assay levels have been found elevated in the serum with carcinomas of the exocrine pancreas, the colon and rectum, the stomach and lung cancer (9-10-11). In non malignant gastrointestinal disorders, elevation of CA 19-9 is less common than that of CEA (12-13-14).

intended use

The EIAgen GI Marker CA19-9 kit is intended for the quantitative determination of the cancer associated antigen CA19-9 in human serum.